Given the well-documented role of Pten in prostate cancer and that alteration is found in 30–70% of patients at the time of diagnosis, it seems highly likely that elevation of miR-19a & miR-19b seen in the tissue is functionally associated with tumor development [38]–[40]. Here, PTEN is linked to prostate carcinoma.